US Patent

US10737051 — Nitrogen dioxide storage device

Formulation · Assigned to Vero Biotech Inc · Expires 2035-10-20 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a nitric oxide delivery system that converts liquid nitrogen dioxide to nitric oxide for patient delivery.

USPTO Abstract

A nitric oxide delivery system can include a cassette which is a single use disposable component used to store liquid N 2 O 4 , activate upon operator demand, convert N 2 O 4 to NO 2 via a heating element(s) controlled by a console to deliver NO 2 at a controlled flow rate, direct concentrated NO 2 to a contained pair of conversion cartridges and exhaust NO gas to the console for delivery to the patient.

Drugs covered by this patent

Patent Metadata

Patent number
US10737051
Jurisdiction
US
Classification
Formulation
Expires
2035-10-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Vero Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.